Peter Bloch

Chief Executive Officer at BresoTEC and former Chairman and CEO at Bionik Laboratories.

Peter Bloch has more than 25 years of experience in leading healthcare and technology companies in the role of Chairman, CEO and previously CFO. This includes experience in both large Pharmaceutical (Sanofi -Aventis) and earlier stage Medical Device and Biotechnology companies (Bionik Laboratories, Tribute Pharmaceuticals and Intellivax).

See also:

Bionik Laboratories - Innovative medical device and robotics company developing exoskeleton for users with mobility impairments

Details last updated 28-Jan-2021

Peter Bloch News

Bionik starts production of ARKE GEN2

Bionik Laboratories - 15-Sep-2015

Lower-body exoskeleton has significantly smaller mechanics, improved battery density and power-to...